Prevencio is developing exciting technology for the early detection of heart disease and stroke.
New diagnostic tests are needed for indicating who is in imminent danger of having a heart attack or stroke. Cholesterol panels currently provide predictive value about who has a high risk for cardiovascular disease, and Troponin is a valuable emergency room diagnostic assay that tells who has already had a heart attack. But no diagnostic test is available to tell who is about to have a heart attack or a stroke. Prevencio® is about to change that by introducing novel, vascular diagnostic tools for emergency rooms and cardiology clinics.
Prevencio (TM) is the registered trademark of Prevencio, LLC, a Delaware Limited Liability Corporation. Copyright (2011). All rights reserved.